Theralase Technologies Inc. V.TLT

Dr Sherri's statement of "Virtually No Side Effects"

[skys1]

isn't as yet priced into the stock, IMO. The side effects of Keytruda can be agony. A few years ago  neighbor who was a big guy about 6'4" & 240 lbs and part of our golf group, came down with cancer and had to have treatments every 3 weeks(@$12.9K per probably more now), would sit on his sofa for the next few days and cry, until he passed! RIP Rich.  These oncologists know the agony their patients can go through after the treatments they administer. Don't think that if another treatment appears with higher efficacy that can be administered with ease in only an easy treatment or two with "VIRTUALLY NO SIDE EFFECTS", they wouldn't switch to it if for no other reason than to releave their patients agony. One has told me as much. If that is the case, when TLT's ACT becomes available IMO, the demand for 1433 could be very substantcial. Profits could be huge, not to mention the benefits it could provide cancer patients worldwide. IMO, TLT's potential is unlimited if it can avoid being swallowed up by Big Pharma.

[gojotv!]

"... if it can avoid being swallowed up by Big Pharma." Aye, that is the rub. The potential for success of our anti-cancer PDCs is endless. We don't even need for them to be effective after only two treatments, as is stipulated in this Phase 2 study. In real life, patients can get three, even four or more treatments, until they respond. It is crucial that we, the shareholders

[ScienceFirst]

No way TLT can avoid cutting a deal with a big Pharma.  Why?  Because it doesn't a network of distribution and it would cost way too much to develop one and it would take too long anyway. BioNtech jv with Pfizer in 2018.  In 2019, its IPO was worth 3.4B$.  BioNTech valuation went up to 67B$ before pulling back to 37B$.  So big pharmas can help provide valuation much

[Gooseybear]

My Urologist is vehemently against Keytruda but I have had T1 HG CIS and papillary bladder cancer. Was on BCG and currently NED.

[CancerSlayer]

  I agree skys1....& the versatility of this tech has yet to be priced in imo.  The potential this tech brings to the table as a vaccine (antiviral & anticancer) &/or as an antiviral treatment is also being overlooked by the market imo.  As for being swallowed up by Big Pharma, I can only hope we're able to build more proper value until that day.  Good luck...